UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 30

Sortiert nach

Differential binding of chemokines CXCL1, CXCL2 and CCL2 to mouse glomerular endothelial cells reveals specificity for distinct heparan sulfate domains

PloS one, 2018-09, Vol.13 (9), p.e0201560-e0201560

2018

Volltextzugriff (PDF)

Selection and characterization of a unique phage display-derived antibody against dermatan sulfate

Matrix biology, 2006-09, Vol.25 (7), p.457-461

2006

Volltextzugriff (PDF)

Adult and paediatric patients with minimal change nephrotic syndrome show no major alterations in glomerular expression of sulphated heparan sulphate domains

Nephrology, dialysis, transplantation, 2007-10, Vol.22 (10), p.2886-2893

2007

Volltextzugriff (PDF)

Efficacy of Intravitreal Bevacizumab for Stage 3+ Retinopathy of Prematurity

The New England journal of medicine, 2011-02, Vol.364 (7), p.603-615

2011

Volltextzugriff (PDF)

Refractive outcomes following bevacizumab monotherapy compared with conventional laser treatment: a randomized clinical trial

JAMA ophthalmology, 2014-11, Vol.132 (11), p.1327

2014

Volltextzugriff (PDF)

Blocking of inflammatory heparan sulfate domains by specific antibodies is not protective in experimental glomerulonephritis

PloS one, 2021-12, Vol.16 (12), p.e0261722-e0261722

2021

Volltextzugriff (PDF)

Modulation of heparan sulfate in the glomerular endothelial glycocalyx decreases leukocyte influx during experimental glomerulonephritis

Kidney international, 2014-11, Vol.86 (5), p.932-942

2014

Volltextzugriff (PDF)

Endothelin-1 Induces Proteinuria by Heparanase-Mediated Disruption of the Glomerular Glycocalyx

Journal of the American Society of Nephrology, 2016-12, Vol.27 (12), p.3545-3551

2016

Volltextzugriff (PDF)

Glomerular Endothelial Surface Layer Acts as a Barrier against Albumin Filtration

The American journal of pathology, 2013-05, Vol.182 (5), p.1532-1540

2013

Volltextzugriff (PDF)

Differential Expression of Specific Dermatan Sulfate Domains in Renal Pathology

PloS one, 2015-08, Vol.10 (9), p.e0134946-e0134946

2015

Volltextzugriff (PDF)

The role of heparanase and the endothelial glycocalyx in the development of proteinuria

Nephrology, dialysis, transplantation, 2014-01, Vol.29 (1), p.49-55

2014

Volltextzugriff (PDF)

Cathepsin L is crucial for the development of early experimental diabetic nephropathy

Kidney international, 2016-11, Vol.90 (5), p.1012-1022

2016

Volltextzugriff (PDF)

Interleukin-6 is essential for glomerular immunoglobulin A deposition and the development of renal pathology in Cd37-deficient mice

Kidney international, 2018-06, Vol.93 (6), p.1356-1366

2018

Volltextzugriff (PDF)

Heparanase Is Essential for the Development of Acute Experimental Glomerulonephritis

The American journal of pathology, 2016-04, Vol.186 (4), p.805-815

2016

Volltextzugriff (PDF)

Association of kidney function with changes in the endothelial surface layer

Clinical journal of the American Society of Nephrology, 2014-04, Vol.9 (4), p.698-704

2014

Volltextzugriff (PDF)

Vitamin D attenuates proteinuria by inhibition of heparanase expression in the podocyte

The Journal of pathology, 2015-12, Vol.237 (4), p.472-481

2015

Volltextzugriff (PDF)

Chemokine cooperativity is caused by competitive glycosaminoglycan binding

The Journal of immunology (1950), 2014-04, Vol.192 (8), p.3908-3914

2014

Volltextzugriff (PDF)

Heparan sulfate proteoglycans in glomerular inflammation

Kidney international, 2004-03, Vol.65 (3), p.768-785

2004

Volltextzugriff (PDF)

Glomerular endothelial glycocalyx-derived heparan sulfate inhibits glomerular leukocyte influx and attenuates experimental glomerulonephritis

Frontiers in molecular biosciences, 2023-06, Vol.10, p.1177560-1177560

2023

Volltextzugriff (PDF)

Urinary heparanase activity in patients with Type 1 and Type 2 diabetes

Nephrology, dialysis, transplantation, 2012-07, Vol.27 (7), p.2853-2861

2012

Volltextzugriff (PDF)

Supplemental Therapeutic Oxygen for Prethreshold Retinopathy Of Prematurity (STOP-ROP), a randomized, controlled trial. I: primary outcomes

Pediatrics (Evanston), 2000-02, Vol.105 (2), p.295

2000

Volltextzugriff (PDF)

The role of heparan sulfate as determining pathogenic factor in complement factor H-associated diseases

Molecular immunology, 2015-02, Vol.63 (2), p.203-208

2015

Volltextzugriff (PDF)

In vivo degradation of heparan sulfates in the glomerular basement membrane does not result in proteinuria

Journal of the American Society of Nephrology, 2007-03, Vol.18 (3), p.823-832

2007

Volltextzugriff (PDF)

1,25-Vitamin D3 Deficiency Induces Albuminuria

The American journal of pathology, 2016-04, Vol.186 (4), p.794-804

2016

Volltextzugriff (PDF)

Localization and functional characterization of glycosaminoglycan domains in the normal human kidney as revealed by phage display-derived single chain antibodies

Journal of the American Society of Nephrology, 2005-05, Vol.16 (5), p.1279-1288

2005

Volltextzugriff (PDF)

1 – 25 von 30

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(28)
Mit Volltextzugriff
(27)

Publikationsform

Artikel
(30)

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Differential binding of chemokines CXCL1, CXCL2 and CCL2 to mouse glomerular endothelial cells reveals specificity for distinct heparan sulfate domains

Selection and characterization of a unique phage display-derived antibody against dermatan sulfate

Adult and paediatric patients with minimal change nephrotic syndrome show no major alterations in glomerular expression of sulphated heparan sulphate domains

Efficacy of Intravitreal Bevacizumab for Stage 3+ Retinopathy of Prematurity

Refractive outcomes following bevacizumab monotherapy compared with conventional laser treatment: a randomized clinical trial

Blocking of inflammatory heparan sulfate domains by specific antibodies is not protective in experimental glomerulonephritis

Modulation of heparan sulfate in the glomerular endothelial glycocalyx decreases leukocyte influx during experimental glomerulonephritis

Endothelin-1 Induces Proteinuria by Heparanase-Mediated Disruption of the Glomerular Glycocalyx

Glomerular Endothelial Surface Layer Acts as a Barrier against Albumin Filtration

Differential Expression of Specific Dermatan Sulfate Domains in Renal Pathology

The role of heparanase and the endothelial glycocalyx in the development of proteinuria

Cathepsin L is crucial for the development of early experimental diabetic nephropathy

Interleukin-6 is essential for glomerular immunoglobulin A deposition and the development of renal pathology in Cd37-deficient mice

Heparanase Is Essential for the Development of Acute Experimental Glomerulonephritis

Association of kidney function with changes in the endothelial surface layer

Vitamin D attenuates proteinuria by inhibition of heparanase expression in the podocyte

Chemokine cooperativity is caused by competitive glycosaminoglycan binding

Heparan sulfate proteoglycans in glomerular inflammation

Glomerular endothelial glycocalyx-derived heparan sulfate inhibits glomerular leukocyte influx and attenuates experimental glomerulonephritis

Urinary heparanase activity in patients with Type 1 and Type 2 diabetes

Supplemental Therapeutic Oxygen for Prethreshold Retinopathy Of Prematurity (STOP-ROP), a randomized, controlled trial. I: primary outcomes

The role of heparan sulfate as determining pathogenic factor in complement factor H-associated diseases

In vivo degradation of heparan sulfates in the glomerular basement membrane does not result in proteinuria

1,25-Vitamin D3 Deficiency Induces Albuminuria

Localization and functional characterization of glycosaminoglycan domains in the normal human kidney as revealed by phage display-derived single chain antibodies

Suchergebnisse filtern